Literature DB >> 9778176

Occupational chlorophenol exposure and soft tissue sarcoma risk among men aged 30-60 years.

J A Hoppin1, P E Tolbert, R F Herrick, D S Freedman, B D Ragsdale, K R Horvat, E A Brann.   

Abstract

To evaluate the association of chlorophenol exposure with soft tissue sarcoma risk independent of phenoxyherbicide exposure, the authors analyzed data from the Selected Cancers Study, a population-based case-control study that included 295 male soft tissue sarcoma cases, aged 32-60 years, from eight population-based cancer registries and 1,908 male controls. Chlorophenol exposure was assigned using both an intensity and a confidence estimate by an industrial hygienist based on verbatim job descriptions. Seventeen percent of the jobs rated as high intensity involved wood preservation, while 82% involved cutting oils. Soft tissue sarcoma risk, modeled using conditional logistic regression, was significantly associated with ever having high-intensity chlorophenol exposure (odds ratio = 1.79, 95% confidence interval 1.10-2.88). A duration-response trend was evident among more highly exposed subjects (p for trend < 0.0001). For subjects with 10 or more years of substantial exposure, the odds ratio was 7.78 (95% confidence interval 2.46-24.65). These results suggest that chlorophenol exposure independent of phenoxyherbicides may increase the risk of soft tissue sarcoma. Because of the large number of machinists in the exposed group and the complex composition of cutting fluids, it is possible that another exposure involved in machining is responsible for the observed excess risk.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9778176     DOI: 10.1093/aje/148.7.693

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  9 in total

1.  Adjuvant therapy for high-risk soft tissue sarcoma in the adult.

Authors:  Alessandro Gronchi; Paolo G Casali
Journal:  Curr Treat Options Oncol       Date:  2013-09

Review 2.  Primary multidisciplinary management of extremity soft tissue sarcomas.

Authors:  Paul Clarkson; Peter C Ferguson
Journal:  Curr Treat Options Oncol       Date:  2004-12

3.  Body weight and risk of soft-tissue sarcoma.

Authors:  A Tavani; M Soler; C La Vecchia; E Negri; S Gallus; S Franceschi
Journal:  Br J Cancer       Date:  1999-11       Impact factor: 7.640

4.  Epidemiology and therapies for metastatic sarcoma.

Authors:  Ernest K Amankwah; Anthony P Conley; Damon R Reed
Journal:  Clin Epidemiol       Date:  2013-05-16       Impact factor: 4.790

Review 5.  Toxicological profile of chlorophenols and their derivatives in the environment: the public health perspective.

Authors:  Etinosa O Igbinosa; Emmanuel E Odjadjare; Vincent N Chigor; Isoken H Igbinosa; Alexander O Emoghene; Fredrick O Ekhaise; Nicholas O Igiehon; Omoruyi G Idemudia
Journal:  ScientificWorldJournal       Date:  2013-04-03

6.  The epidemiology of sarcoma.

Authors:  Zachary Burningham; Mia Hashibe; Logan Spector; Joshua D Schiffman
Journal:  Clin Sarcoma Res       Date:  2012-10-04

Review 7.  Pentachlorophenol and cancer risk: focusing the lens on specific chlorophenols and contaminants.

Authors:  Glinda S Cooper; Samantha Jones
Journal:  Environ Health Perspect       Date:  2008-08       Impact factor: 9.031

8.  Clustering of cancer among families of cases with Hodgkin Lymphoma (HL), Multiple Myeloma (MM), Non-Hodgkin's Lymphoma (NHL), Soft Tissue Sarcoma (STS) and control subjects.

Authors:  Helen H McDuffie; Punam Pahwa; Chandima P Karunanayake; John J Spinelli; James A Dosman
Journal:  BMC Cancer       Date:  2009-02-27       Impact factor: 4.430

9.  Sex-specific incidence and temporal trends in solid tumours in young people from Northern England, 1968-2005.

Authors:  Brooke L Magnanti; M Tevfik Dorak; Louise Parker; Alan W Craft; Peter W James; Richard Jq McNally
Journal:  BMC Cancer       Date:  2008-04-03       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.